Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for O70279

Entry ID Method Resolution Chain Position Source
AF-O70279-F1 Predicted AlphaFoldDB

20 variants for O70279

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3405834173 16 A>P No EVA
rs3389402635 84 R>L No EVA
rs3389405126 97 I>T No EVA
rs3389374070 106 V>D No EVA
rs3389398507 123 L>M No EVA
rs3389409602 193 K>E No EVA
rs3389413276 233 G>D No EVA
rs3389402248 236 D>G No EVA
rs3389374088 255 L>P No EVA
rs3389395050 258 P>S No EVA
rs3389384362 262 A>G No EVA
rs3389374028 267 Q>L No EVA
rs3389402638 282 K>Q No EVA
rs3389374092 345 P>L No EVA
rs3389365235 380 R>T No EVA
rs3389398535 404 L>I No EVA
rs3389405119 428 S>Y No EVA
rs3389394998 434 P>R No EVA
rs3389374004 446 A>V No EVA
rs3389384365 455 L>P No EVA

No associated diseases with O70279

No regional properties for O70279

Type Name Position InterPro Accession
No domain, repeats, and functional sites for O70279

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
catalytic step 2 spliceosome A spliceosomal complex that contains three snRNPs, including U5, bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the associated snRNPs.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

3 GO annotations of biological process

Name Definition
mRNA processing Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.
nervous system development The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
RNA splicing The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q96DF8 ESS2 Splicing factor ESS-2 homolog Homo sapiens (Human) PR
10 20 30 40 50 60
MGTPGTSAGA LFLSSASAPS RKRAAGEAGE AGVARSRQRV LDEEEYIEGL QTVIQRDFFP
70 80 90 100 110 120
DVEKLQAQKE YLEAEENGDL ERMRQIAIKF GSALGKISRE PPPPYVTPAT FETPEVHPGS
130 140 150 160 170 180
AVLGNKPRPQ GRDLDDGEAG EEEEKEPLPS LDVFLSQYTS EDNASFQEIM EVAKEKSHAR
190 200 210 220 230 240
HAWLYQAEEE FEKRQKDNLE LPSAEHQAIE SSQAGVETWK YKAKNSLMYY PEGVPDEEQL
250 260 270 280 290 300
FKKPRQIVHK NTRFLRDPFS QALSRSQLQQ AAALNAQHKQ GKVGPDGKEL IPQESPRVGG
310 320 330 340 350 360
FGFVATPSPA PGVNESPLMT WGEVENTPLR VEGSESPYVD RTPGPTFKIL EPGRRERLGL
370 380 390 400 410 420
KMANEAAAKN RAKKQEALRR VTENLASLTP KGLSPAMSPA LQRLVSRTAS KYTDRALRAS
430 440 450 460 470
YTPSPARSSH LKTPAGGPQT PTSTPAPGSA TRTPLTQDPA SITDNLLQLP ARRKASDFF